Aetna considers ultra rapid detoxification (UROD) experimental, investigational, or unproven as a clinical detoxification treatment and for all other indications, because its effectiveness has not been established. The procedure induces opiate detoxification with a bolus of very high-dose naloxone under general anesthesia or heavy sedation, followed by a slow infusion of low-dose naloxone. There is a reported risk of serious adverse events, including death, with the use of anesthetics, and the policy's cited NICE guidance states that ultra-rapid detoxification under general anesthesia or heavy sedation must not be offered.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
01Billing team: Do not bill ultra rapid detoxification (UROD) as a clinical detoxification treatment or for any other indication in this policy, because Aetna considers it experimental, investigational, or unproven.
02There is no specific CPT code for UROD.
03The ICD-10 codes listed as not covered for the indications in this policy include opioid abuse (F11.10 through F11.19), opioid dependence (F11.20 through F11.29), and poisoning by or adverse effects of opiates and related narcotics (T40.0X1 through T40.4X5, T40.601 through T40.695, and T40.3X5 for methadone).
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.